What's behind the push to make peptide therapies more readily available

According to NPR News, compounding pharmacies are seeking regulatory approval to legally produce peptide therapies currently sold as unproven longevity treatments through online grey markets to meet growing demand.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton